Clinical trial
A Novel Therapy With a 1-Month Ultrashort Regimen to Halt Progression From Latent Infection to Active Tuberculosis Among Close Contacts (The TB-YOUTH Study)
NCT06022146 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Novel Therapy With a 1-Month Ultrashort Regimen to Halt Progression From Latent Infection to Active Tuberculosis Among Close Contacts (The TB-YOUTH Study)
- Lead sponsor
- Huashan Hospital
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- September 1, 2023
- Completion date
- September 1, 2026
- Enrollment
- 3,520 (estimated)
- Sites
- 66
Conditions
As the registry lists them; a condition with its own page is linked.